Exact Sciences Corporation - Common Stock (NQ:EXAS)

101.25 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2025 Add to My Watchlist

Price and Volume

Volume	182
Open	101.25
Bid (Size)	100.96 (200)
Ask (Size)	101.45 (100)
Prev. Close	101.25
Today's Range	101.25 - 101.25
52wk Range	38.81 - 101.87
Shares Outstanding	171,948,769
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Overrated Stocks That Concern Us

December 03, 2025

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro...

Via StockStory

Here's Why Grail Soared, Again, in November ↗

December 02, 2025

A combination of operational improvements and developments at its key rival bolstered the stock recently.

Via The Motley Fool

Performance

YTD	+77.9%	+77.9%
1 Month	+51.2%	+51.2%
3 Month	+105.5%	+105.5%
6 Month	+83.5%	+83.5%
1 Year	+67.2%	+67.2%

More News

This Top Dividend King Just Became an Even Better Buy ↗

November 30, 2025

Via The Motley Fool

Halper Sadeh LLC Encourages SEE, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights

November 27, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Exact Sciences Stock Soars To 4-Year High Even As Wall Street Piles On Downgrades After Abbott Deal — Retail Traders Take Profits ↗

November 20, 2025

Via Stocktwits

Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover ↗

November 20, 2025

Via Stocktwits

Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium

November 24, 2025

From Exact Sciences Corp.

Via Business Wire

Unusual volume stocks are being observed in Monday's session. ↗

November 24, 2025

Via Chartmill

Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks

November 23, 2025

Via StockStory

Halper Sadeh LLC Encourages EXAS, NVRI, MRUS Shareholders to Contact the Firm to Discuss Their Rights

November 22, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

November 21, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More ↗

November 20, 2025

Via The Motley Fool

Why Exact Sciences Rallied Over 50% This Week ↗

November 20, 2025

Via The Motley Fool

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Exact Sciences Corporation (Nasdaq – EXAS)

November 20, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Why Exact Sciences Stock Surged Today ↗

November 20, 2025

Via The Motley Fool

Tech Stocks Fall Despite Nvidia's Beat, Walmart Jumps 6%: What's Moving Markets Thursday? ↗

November 20, 2025

Via Benzinga

Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday ↗

November 20, 2025

Via Benzinga

Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics ↗

November 20, 2025

Via Benzinga

EXAS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Exact Sciences Corporation is Fair to Shareholders

November 20, 2025

From Halper Sadeh LLC

Via Business Wire

Abbott To Acquire Exact Sciences For Up To $23B ↗

November 20, 2025

Via Stocktwits

Why Exact Sciences Stock Blasted Nearly 24% Higher Today ↗

November 19, 2025

Via The Motley Fool

2 Surging Stocks with Competitive Advantages and 1 We Question

November 16, 2025

Via StockStory

Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome’s Blood-Based Colorectal Cancer Screening Tests

November 10, 2025

From Exact Sciences Corp.

Via Business Wire

The 5 Most Interesting Analyst Questions From Exact Sciences’s Q3 Earnings Call

November 10, 2025

Via StockStory

2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗

November 08, 2025

Via The Motley Fool

Frequently Asked Questions

Is Exact Sciences Corporation - Common Stock publicly traded?

Yes, Exact Sciences Corporation - Common Stock is publicly traded.

What exchange does Exact Sciences Corporation - Common Stock trade on?

Exact Sciences Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Exact Sciences Corporation - Common Stock?

The ticker symbol for Exact Sciences Corporation - Common Stock is EXAS on the Nasdaq Stock Market

What is the current price of Exact Sciences Corporation - Common Stock?

The current price of Exact Sciences Corporation - Common Stock is 101.25

When was Exact Sciences Corporation - Common Stock last traded?

The last trade of Exact Sciences Corporation - Common Stock was at 12/03/25 04:00 PM ET

What is the market capitalization of Exact Sciences Corporation - Common Stock?

The market capitalization of Exact Sciences Corporation - Common Stock is 17.41B

How many shares of Exact Sciences Corporation - Common Stock are outstanding?

Exact Sciences Corporation - Common Stock has 17B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.